MedPath

Ornithine

Generic Name
Ornithine
Brand Names
Primene
Drug Type
Small Molecule
Chemical Formula
C5H12N2O2
CAS Number
70-26-8
Unique Ingredient Identifier
E524N2IXA3

Overview

Produced during the urea cycle, ornithine is an amino acid produced from the splitting off of urea from arginine. L-Ornithine allows for the disposal of excess nitrogen and acts as a precursor of citrulline and arginine.

Background

Produced during the urea cycle, ornithine is an amino acid produced from the splitting off of urea from arginine. L-Ornithine allows for the disposal of excess nitrogen and acts as a precursor of citrulline and arginine.

Indication

Used for nutritional supplementation, also for treating dietary shortage or imbalance. It has been claimed that ornithine improves athletic performance, has anabolic effects, has wound-healing effects, and is immuno-enhancing.

Associated Conditions

  • Hepatic Encephalopathy (HE)

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

PRIMENE 10% AMINO ACID INTRAVENOUS INFUSION
Manufacturer:BIEFFE MEDITAL S.P.A.
Form:INJECTION
Strength:3.18 g/l
Online:Yes
Approved: 1998/09/23
Approval:SIN10252P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath